IBDEI0N6 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10811,1,4,0)
 ;;=4^D72.829
 ;;^UTILITY(U,$J,358.3,10811,2)
 ;;=^5002379
 ;;^UTILITY(U,$J,358.3,10812,0)
 ;;=D72.9^^47^521^37
 ;;^UTILITY(U,$J,358.3,10812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10812,1,3,0)
 ;;=3^White Blood Cells Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,10812,1,4,0)
 ;;=4^D72.9
 ;;^UTILITY(U,$J,358.3,10812,2)
 ;;=^5002381
 ;;^UTILITY(U,$J,358.3,10813,0)
 ;;=L02.91^^47^522^1
 ;;^UTILITY(U,$J,358.3,10813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10813,1,3,0)
 ;;=3^Abcess,Cutaneous,Unspec
 ;;^UTILITY(U,$J,358.3,10813,1,4,0)
 ;;=4^L02.91
 ;;^UTILITY(U,$J,358.3,10813,2)
 ;;=^5009016
 ;;^UTILITY(U,$J,358.3,10814,0)
 ;;=L11.9^^47^522^2
 ;;^UTILITY(U,$J,358.3,10814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10814,1,3,0)
 ;;=3^Acantholytic Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,10814,1,4,0)
 ;;=4^L11.9
 ;;^UTILITY(U,$J,358.3,10814,2)
 ;;=^5009094
 ;;^UTILITY(U,$J,358.3,10815,0)
 ;;=L83.^^47^522^3
 ;;^UTILITY(U,$J,358.3,10815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10815,1,3,0)
 ;;=3^Acanthosis Nigricans
 ;;^UTILITY(U,$J,358.3,10815,1,4,0)
 ;;=4^L83.
 ;;^UTILITY(U,$J,358.3,10815,2)
 ;;=^1451
 ;;^UTILITY(U,$J,358.3,10816,0)
 ;;=L70.9^^47^522^4
 ;;^UTILITY(U,$J,358.3,10816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10816,1,3,0)
 ;;=3^Acne,Unspec
 ;;^UTILITY(U,$J,358.3,10816,1,4,0)
 ;;=4^L70.9
 ;;^UTILITY(U,$J,358.3,10816,2)
 ;;=^5009273
 ;;^UTILITY(U,$J,358.3,10817,0)
 ;;=L57.0^^47^522^5
 ;;^UTILITY(U,$J,358.3,10817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10817,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,10817,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,10817,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,10818,0)
 ;;=N65.0^^47^522^16
 ;;^UTILITY(U,$J,358.3,10818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10818,1,3,0)
 ;;=3^Breast,Reconstructed Deformity
 ;;^UTILITY(U,$J,358.3,10818,1,4,0)
 ;;=4^N65.0
 ;;^UTILITY(U,$J,358.3,10818,2)
 ;;=^5015800
 ;;^UTILITY(U,$J,358.3,10819,0)
 ;;=N64.9^^47^522^9
 ;;^UTILITY(U,$J,358.3,10819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10819,1,3,0)
 ;;=3^Breast Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,10819,1,4,0)
 ;;=4^N64.9
 ;;^UTILITY(U,$J,358.3,10819,2)
 ;;=^5015799
 ;;^UTILITY(U,$J,358.3,10820,0)
 ;;=N65.1^^47^522^15
 ;;^UTILITY(U,$J,358.3,10820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10820,1,3,0)
 ;;=3^Breast Reconstructed Disproportion
 ;;^UTILITY(U,$J,358.3,10820,1,4,0)
 ;;=4^N65.1
 ;;^UTILITY(U,$J,358.3,10820,2)
 ;;=^5015801
 ;;^UTILITY(U,$J,358.3,10821,0)
 ;;=N60.92^^47^522^10
 ;;^UTILITY(U,$J,358.3,10821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10821,1,3,0)
 ;;=3^Breast Dysplasia,Benign Mammary,Left
 ;;^UTILITY(U,$J,358.3,10821,1,4,0)
 ;;=4^N60.92
 ;;^UTILITY(U,$J,358.3,10821,2)
 ;;=^5134091
 ;;^UTILITY(U,$J,358.3,10822,0)
 ;;=N60.91^^47^522^11
 ;;^UTILITY(U,$J,358.3,10822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10822,1,3,0)
 ;;=3^Breast Dysplasia,Benign Mammary,Right
 ;;^UTILITY(U,$J,358.3,10822,1,4,0)
 ;;=4^N60.91
 ;;^UTILITY(U,$J,358.3,10822,2)
 ;;=^5015788
 ;;^UTILITY(U,$J,358.3,10823,0)
 ;;=N62.^^47^522^12
 ;;^UTILITY(U,$J,358.3,10823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10823,1,3,0)
 ;;=3^Breast Hypertrophy
 ;;^UTILITY(U,$J,358.3,10823,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,10823,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,10824,0)
 ;;=N61.^^47^522^13
 ;;^UTILITY(U,$J,358.3,10824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10824,1,3,0)
 ;;=3^Breast Inflammatory Disorders
 ;;^UTILITY(U,$J,358.3,10824,1,4,0)
 ;;=4^N61.
 ;;^UTILITY(U,$J,358.3,10824,2)
 ;;=^5015789
 ;;^UTILITY(U,$J,358.3,10825,0)
 ;;=N63.^^47^522^14
